T. Rowe Price Associates’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-24,600
| Closed | -$55K | – | 3024 |
|
|
2022
Q2 | $55K | Buy |
24,600
+10,297
| +72% | +$23K | ﹤0.01% | 2838 |
|
|
2022
Q1 | $89K | Sell |
14,303
-1,585
| -10% | -$9.86K | ﹤0.01% | 2860 |
|
|
2021
Q4 | $201K | Sell |
15,888
-78,666
| -83% | -$995K | ﹤0.01% | 2757 |
|
|
2021
Q3 | $8.67M | Buy |
94,554
+55,154
| +140% | +$5.06M | ﹤0.01% | 1434 |
|
|
2021
Q2 | $2.09M | Buy |
+39,400
| New | +$2.09M | ﹤0.01% | 1719 |
|
|
2020
Q3 | – | Sell |
-77,166
| Closed | -$3.57M | – | 2610 |
|
|
2020
Q2 | $3.57M | Sell |
77,166
-6,195
| -7% | -$287K | ﹤0.01% | 1426 |
|
|
2020
Q1 | $3.8M | Sell |
83,361
-13,845
| -14% | -$631K | ﹤0.01% | 1376 |
|
|
2019
Q4 | $5.46M | Buy |
+97,206
| New | +$5.46M | ﹤0.01% | 1384 |
|